Dementia is the biggest health challenge facing the UK’s ageing population with 900,000 currently living with the disease and predicted to increase to 1.6 million by 2050. Now, for the first time, a ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

A recent study conducted by the Chinese Academy of Sciences has brought attention to a potential link between frequent ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

Additional Money for Dementia-Related Respite Care . A new Medicare program called Guiding an Improved Dementia Experience ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.